Then, it was confirmed that miR-210 could regulate EFNA3 expression; further mechanistic analysis revealed that miR-210 could promote tumor progression via the PI3K/AKT/VEGFA or Wnt/Β-catenin/RHOA pathways. The gene discussed is RHOA; the disease is neoplasm.